What is CNS Pharmaceuticals Inc?
, a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.25M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.